Mesothelioma Pleural is a lethal cancer that initially affects the thin membrane enveloping the lungs. This affliction is mostly caused by exposure to asbestos. Currently about 3000 cases are reported in the United States every year. But according to reliable estimates, nearly 8 million people have been exposed to asbestos during the past fifty years and about .3 million new cases would turn up by 2030. Higher rate of incidence is noted in the Pacific and Mid-Atlantic States.

The disease is almost always fatal. If it is detected early, surgery could be helpful. But the problem is that Mesothelioma Pleural has a long latent period of 20 to 40 years or more and by the time it is diagnosed the cancer would be usually in an advanced stage. There is no universally accepted line of treatment as of now. Chemotherapy is not considered effective. Several combination therapies are tried.

Radiation may be of use, particularly as a palliative measure. Here the problem is that since mesothelioma is resistant to radiation, high doses have to be applied. This, not only kill the cancerous cells but also the good ones. To overcome the difficulty, many doctors who treat mesothelioma pleural patients are employing a century old procedure known as Brachytherapy, which was being, and still is, used for treatment of certain other cancers.

Brachytherapy today is a high-tech and precise form of radiation. It is a process applied internally instead of through a gadget outside the body. Radioactive sources (sealed in needles, catheters, seeds or wires) are planted on the tumor or very close to it. By this process the radiation is focused on the bad cells and therefore spares the good ones. This has been found to be effective.

Like all radiation, Brachytherapy also has side effects. But they are minor ones like short duration soreness in the area where the procedure is done. There is nothing to worry about if the patient follows the doctors instructions.